glp-1 drugs eli lilly FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly's Obesity Pill Appears
Description
October 5, 2011
Clinicians should also consider alternative medical explanations for new-onset fatigue, including thyroid dysfunction, anemia, sleep apnea (which may improve or persist despite weight loss), chronic kidney disease, or cardiovascular conditions
2015 Jul 2;373(1):11-22
, & Goldstein, R
Weight loss has been associated with improvement in HS symptoms [30,31,32]
